The deal potentially caps a two-year acquisition process of the Houston company’s stock.
Houston Biz Journal
Remaining shares in Houston biotech co. scooped up for 5M
The deal potentially caps a two-year acquisition process of the Houston company’s stock.
Houston Biz Journal
Remaining shares in Houston biotech co. scooped up for 5M